Sleep aid won't hit U.S. market till end 2008 -Lundbeck
COPENHAGEN (Reuters) - Sleep aid drug gaboxadol will not hit the U.S. market until the end of 2008 after makers Merck & Co. Inc. and Lundbeck delayed their application for U.S. approval, a Lundbeck official said on Friday.
Music calendar
Skagit Opera: "Carmen," 7:30 p.m. Fridays, 2 p.m. Sundays, through Oct. 15, McIntyre Hall, 2501 East College Way, Mount Vernon, $18 to $48; 360-422-5070, 866-624-6897, www.skagitopera.org.
<< Home